OTCMKTS:CZMWY Carl Zeiss Meditec (CZMWY) Stock Price, News & Analysis → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free CZMWY Stock Alerts $109.69 +4.48 (+4.26%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range$108.87▼$110.3550-Day Range$103.20▼$132.3852-Week Range$77.44▼$138.40Volume3,081 shsAverage Volume909 shsMarket CapitalizationN/AP/E Ratio119.23Dividend Yield0.27%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort Interest Get Carl Zeiss Meditec alerts: Email Address Ad Weiss RatingsThe only accurate crypto trading system I know …Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.Here's what our expert says you should buy before April 14. About Carl Zeiss Meditec Stock (OTCMKTS:CZMWY)Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.Read More CZMWY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CZMWY Stock News HeadlinesApril 22, 2024 | finance.yahoo.comWhat Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?March 25, 2024 | finance.yahoo.comCarl Zeiss Meditec's (ETR:AFX) investors will be pleased with their respectable 63% return over the last five yearsApril 24, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...March 21, 2024 | msn.comCarl Zeiss Meditec AG goes ex dividend tomorrowFebruary 29, 2024 | finance.yahoo.comInstitutions own 23% of Carl Zeiss Meditec AG (ETR:AFX) shares but private companies control 59% of the companyFebruary 13, 2024 | finance.yahoo.comCarl Zeiss Meditec AG (CZMWY)January 26, 2024 | seekingalpha.comCarl Zeiss: We've Seen Outperformance, But I See More Upside PotentialJanuary 11, 2024 | finanznachrichten.deCarl Zeiss Meditec AG: U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISSApril 24, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...December 19, 2023 | msn.comCarl Zeiss Meditec to acquire Dutch Ophthalmic for around $1.08BDecember 18, 2023 | finance.yahoo.comCarl Zeiss Meditec Full Year 2023 Earnings: EPS Beats ExpectationsDecember 15, 2023 | markets.businessinsider.comEQS-News: Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)December 15, 2023 | markets.businessinsider.comEQS-Adhoc: Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.December 15, 2023 | finance.yahoo.comCarl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)December 15, 2023 | finance.yahoo.comZeiss Meditec buys Dutch firm for nearly 1 bln eurosNovember 27, 2023 | finance.yahoo.comAre Strong Financial Prospects The Force That Is Driving The Momentum In Carl Zeiss Meditec AG's ETR:AFX) Stock?November 13, 2023 | finance.yahoo.comShould You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €84.52?October 24, 2023 | msn.comCarl Zeiss Meditec: Premiums Are Proven To Be Dicey In This MarketSeptember 23, 2023 | fool.comCarl Zeiss Meditec Ag (ETR: AFX)September 5, 2023 | finance.yahoo.comEstimating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)August 8, 2023 | msn.comCarl Zeiss Meditec: One Of The Highest Premiums I'll AcceptJuly 28, 2023 | seekingalpha.comCZMWF Carl Zeiss Meditec AGJuly 4, 2023 | finance.yahoo.comThere's Been No Shortage Of Growth Recently For Carl Zeiss Meditec's (ETR:AFX) Returns On CapitalJune 16, 2023 | fool.comCarl Zeiss Meditec Ag (OTC: CZMWF)June 6, 2023 | finance.yahoo.comShould You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?April 12, 2023 | finance.yahoo.comInstitutions own 22% of Carl Zeiss Meditec AG (ETR:AFX) shares but private companies control 59% of the companyFebruary 19, 2023 | finance.yahoo.comCarl Zeiss Meditec First Quarter 2023 Earnings: Revenues Beat Expectations, EPS LagsSee More Headlines Receive CZMWY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 4/9 Dividend3/21/2024Ex-Dividend for 4/10 Dividend3/22/2024Dividend Payable4/09/2024Dividend Payable4/10/2024Today4/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:CZMWY CUSIPN/A CIKN/A Webwww.zeiss.com Phone493641220115FaxN/AEmployees4,823Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio119.23 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesDr. Markus WeberCEO & Chairman of Management BoardMr. Justus Felix Wehmer (Age 59)CFO & Member of the Management Board Comp: $650.23kDr. Christian Munster (Age 53)Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board Stefanie SpanagelChief Operating OfficerMr. Sebastian FrericksDirector of Investor RelationsEva-Maria HeineChief Human Resources OfficerMr. Steven C. Schallhorn M.D.Chief Medical Officer for Global Ophthalmic DevicesMr. Andrew ChangHead of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc.Dr. Euan S. Thomson Ph.D. (Age 61)President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit Mr. Magnus ReibenspiessHead of the Microsurgery Strategic Business Unit - ZEISS Medical TechnologyMore ExecutivesKey CompetitorsAddLife AB (publ)OTCMKTS:ADDLFAnsellOTCMKTS:ANSLYAnsellOTCMKTS:ANSLFAsahi InteccOTC:AHICFBATM Advanced CommunicationsOTCMKTS:BTAVFView All Competitors CZMWY Stock Analysis - Frequently Asked Questions Should I buy or sell Carl Zeiss Meditec stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CZMWY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CZMWY, but not buy additional shares or sell existing shares. View CZMWY analyst ratings or view top-rated stocks. How have CZMWY shares performed in 2024? Carl Zeiss Meditec's stock was trading at $109.1439 at the beginning of 2024. Since then, CZMWY stock has increased by 0.5% and is now trading at $109.69. View the best growth stocks for 2024 here. Are investors shorting Carl Zeiss Meditec? Carl Zeiss Meditec saw a increase in short interest in March. As of March 31st, there was short interest totaling 400 shares, an increase of 100.0% from the March 15th total of 200 shares. Based on an average daily volume of 900 shares, the short-interest ratio is currently 0.4 days. View Carl Zeiss Meditec's Short Interest. How often does Carl Zeiss Meditec pay dividends? What is the dividend yield for Carl Zeiss Meditec? Carl Zeiss Meditec declared a dividend on Tuesday, February 27th. Investors of record on Monday, March 25th will be given a dividend of $0.8282 per share on Wednesday, April 10th. The ex-dividend date is Friday, March 22nd. Read our dividend analysis for CZMWY. Is Carl Zeiss Meditec a good dividend stock? Carl Zeiss Meditec (OTCMKTS:CZMWY) pays an annual dividend of $0.30 per share and currently has a dividend yield of 1.36%. The dividend payout ratio is 32.64%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for CZMWY. How do I buy shares of Carl Zeiss Meditec? Shares of CZMWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CZMWY) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingNew Trump BombshellThe Freeport SocietyThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carl Zeiss Meditec AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
